Sclerosing Cholangitis Therapy
Studies from General Hospital describe new findings in sclerosing cholangitis therapy
Published in Biotech Business Week, June 9th, 2008
Researchers detail in 'High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective,' new data in sclerosing cholangitis. "Ursodeoxycholic acid (UDCA) has been shown to improve serum liver tests in primary sclerosing cholangitis (PSC), but controlled trials have shown inconsistent effects on liver histology, and did not reveal a survival benefit. This pilot, randomised dose-ranging trial attempted to determine whether further enrichment of the bile acid pool with UDCA would lead to an improvement in outcome for PSC patients," scientists writing in the Journal of Hepatology report.
"Thirty-one patients with PSC were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Academy of Neurology
Guideline: Vertigo can be treated easily and quickly - American Academy of Neurology
Ibuprofen, aspirin, naproxen may be equally effective at reducing risk of Alzheimer's disease - Beth Israel Deaconess Medical Center
New method effective in detecting dangerous coronary plaque - Broad Institute of Mit and Harvard
New insights into cellular reprogramming revealed by genomic analysis - Children's Hospital of Pittsburgh
Pittsburgh scientists find protein may be key to new therapies for elevated triglycerides - International & American Association for Dental Research
NIDCR strategies for future scientific success - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
